Azenta restructures Multiomics unit, to close three North American labs
AZTA•Azenta will close three North American labs as it restructures its Multiomics segment, with annualized savings projected at about $11 million. It expects $11 million to $13 million in pre-tax charges, mostly in fiscal 2027, and aims to largely complete the actions by March 31, 2027.
1. Restructuring plans
Azenta is consolidating its North American lab network, streamlining operations and cutting jobs in its Multiomics segment. The company estimates pre-tax charges of $11 million to $13 million, including about $9 million in asset impairments, and expects future cash costs of about $7 million, mainly severance and restructuring expenses of roughly $3 million. Annualized cost savings are projected at about $11 million once the changes are fully implemented.
